Property Summary

NCBI Gene PubMed Count 26
PubMed Score 30.11
PubTator Score 32.78

Knowledge Summary


No data available


  Disease Sources (3)

Disease Target Count P-value
psoriasis 6685 4.06037489213613E-154
non-small cell lung cancer 2798 1.28591173601014E-16
breast carcinoma 1614 4.37921540631363E-15
pituitary cancer 1972 2.79491468858825E-8
Breast cancer 3099 6.56111820984679E-8
cystic fibrosis 1670 1.25789536883129E-7
juvenile dermatomyositis 1189 2.93274508739504E-5
medulloblastoma, large-cell 6234 6.80597005916031E-5
intraductal papillary-mucinous carcinoma (IPMC) 2988 7.96916868282517E-5
invasive ductal carcinoma 2950 9.09127106351789E-4
acute quadriplegic myopathy 1157 9.86709873485443E-4
ulcerative colitis 2087 0.00125871903940591
ductal carcinoma in situ 1745 0.00187117999637976
intraductal papillary-mucinous adenoma (IPMA) 2956 0.00488794038642096
ovarian cancer 8492 0.0112317088599973
autosomal dominant Emery-Dreifuss muscular dystrophy 499 0.0174841993506293
astrocytic glioma 2241 0.0422025348740577
Disease Target Count Z-score Confidence
Cardiovascular system disease 194 0.0 2.0
Disease Target Count Z-score Confidence
Congenital diaphragmatic hernia 44 3.16 1.6
Congenital heart disease 63 3.11 1.6



Accession Q9BT81 B4DKV0 Q53YD0


  Ortholog (6)

Species Source
Macaque OMA EggNOG Inparanoid
Mouse OMA Inparanoid
Rat OMA Inparanoid
Cow OMA Inparanoid
Opossum EggNOG Inparanoid
Xenopus OMA EggNOG Inparanoid

Gene RIF (19)

26944317 the HMG-box is a key domain of SOX7 for negatively regulating the Wnt/beta-catenin signaling pathway when functioning as a tumor suppressor in a glioma.
25940713 The results provided unequivocal evidence for a novel tumor suppressor role of SOX7 in acute myeloid leukemia
25407488 Ectopic expression of miR-492 led to downregulation of SOX7 protein.
25297608 The expression of SOX7 correlates with tumor progression as a tumor suppressor, possibly through the Wnt/beta-catenin signaling pathway in ovarian cancers, suggesting that SOX7 may be a promising prognostic marker.
25073511 Low SOX7 expression is associated with hepatocellular carcinoma.
24816720 SOX7 plays an important inhibitory role in hepatocarcinogenesis, and might be a novel target for hepatocellular carcinoma therapy.
24788044 Decreased expression of Sox7 correlates with the upregulation of the Wnt/beta-catenin signaling pathway and the poor survival of gastric cancer patients.
24558429 miR-184 represents a potential onco-miR and plays an important role in HCC progression by suppressing SOX7 expression
24012678 SOX7 acts as a tumor suppressor in breast cancer.
23557216 SOX7 is a novel tumor suppressor gene silenced in the majority of NSCLC samples.

AA Sequence

LSGHVPVSQVTPTGPTETSLISVLADATATYYNSYSVS                                    351 - 388

Text Mined References (27)

PMID Year Title
26944317 2016 SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/?-catenin signaling.
25940713 2015 Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.
25416956 2014 A proteome-scale map of the human interactome network.
25407488 2015 MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
25297608 2014 Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/?-catenin signaling pathway.
25073511 2014 miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.
24816720 2014 The suppressive role of SOX7 in hepatocarcinogenesis.
24788044 2014 Decreased expression of Sox7 correlates with the upregulation of the Wnt/?-catenin signaling pathway and the poor survival of gastric cancer patients.
24558429 2014 Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma.
24012678 2013 The regulation of SOX7 and its tumor suppressive role in breast cancer.